Effect of short term use of oral contraceptives on fibrinolytic activity of the blood.
D001695:Biology; D001769:Blood; D001777:Blood Coagulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004194:Disease; D004617:Embolism; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D005342:Fibrinolysis; D009644:Norgestrel; D010827:Physiology; D012106:Research; D013923:Thromboembolism; D013927:Thrombosis; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D009644:Norgestrel; D004997:Ethinyl Estradiol
Biology; Blood Coagulation Effects; Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Diseases; Embolism; Ethinyl Estradiol--side effects; Family Planning; Fibrinolysis; Hematological Effects; Hemic System; Norgestrel--side effects; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Research Methodology; Thromboembolism; Thrombosis--etiology; Vascular Diseases